HopeStage
Back to all studies
RecruitingNCT05665465

Brain responses to nicotine and childhood adversity in young nonsmokers

About this titleRead the official source — NCT05665465
Medication studyAges 18–21United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 21 years.

Listed locations
DurhamSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 19, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
150
Sponsor
Duke University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 21 Years
Official registry ID
NCT05665465
Official title
Show the full official title

Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking

Recruitment & locations

Currently recruiting

Durham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Duke University, a university.

Does this study involve medication?

Yes. The study involves medication, including Nicotine nasal spray 0.5 mg and Placebo.

Who can participate?

Listed age limits: 18 years to 21 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies